An Alternating Regimen of Irinotecan/ 5-Fluorouracil/Folinic Acid and Oxaliplatin/ 5-Fluorouracil/Folinic Acid in Metastatic Colorectal Cancer: A Phase II Trial

Publisher： Karger

E-ISSN： 1423-0232|69|4|283-289

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.4, 2005-12, pp. : 283-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiotoxicity in 5-Fluorouracil–Folinic Acid Treatment for Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 324-327

Karger

Access to resources Recommend Favorite

A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma

By  

Oncology, Vol. 64, Iss. 1, 2002-12 ,pp. : 25-27

Karger

Access to resources Recommend Favorite

Gefitinib in Combination with 5-Fluorouracil (5-FU)/Folinic Acid and Irinotecan in Patients with 5-FU/Oxaliplatin- Refractory Colorectal Cancer: A Phase I/II Study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO)

By  

Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. : 563-567

Karger

Access to resources Recommend Favorite

Phase II Study of a Weekly 24-Hour Infusion with 5-Fluorouracil and Simultaneous Sodium – Folinic Acid in the First-Line Treatment of Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 457-462

Karger

Access to resources Recommend Favorite

Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 444-447

Karger

Access to resources Recommend Favorite